In early January 2025, Bridging the Gap panelists George Eastwood and Patrick Hanley visited Washington, D.C., to advocate for increased support and funding for life-saving cell and gene therapies. Insights from our January 2025 Bridging the Gap Webinar During its first year, the Bridging the Gap Webinar Series, sponsored by Azenta Life Sciences and the […]
View Blog
Insights from our December 2024 Bridging the Gap Webinar Groundbreaking advancements in cell and gene therapies offer unprecedented hope for patients battling cancers, autoimmune diseases, and genetic disorders. Yet, transforming academic breakthroughs into therapies ready for patients is a complex and challenging journey. Issues such as scalable manufacturing processes, navigating diverse regulatory frameworks, and expanding […]
View Blog
Recap from the November 2024 Bridging the Gap webinar Pictured in photo: Sickle cell warrior Jimi Olaghere climbed Mt. Kilimanjaro after receiving advanced gene therapy. The incredible potential of gene therapies like CAR-T and CRISPR to cure genetic diseases and cancers marks a new era in medicine, yet most patients still lack access to these life-saving […]
View Blog
Recap from the October 2024 Bridging the Gap webinar In the rapidly advancing world of cell and gene therapy, we are witnessing groundbreaking innovations that have the potential to cure once-incurable diseases like cancer and sickle cell. Yet, as these transformative therapies emerge, a troubling reality persists: access to these life-saving treatments remains limited. Despite […]
View Blog
Recap from the September 2024 Bridging the Gap webinar Access to life-saving cell and gene therapies is one of the most critical challenges facing healthcare today. While these therapies offer remarkable hope for patients battling life-threatening conditions like cancer and rare genetic diseases, the reality is that only a fraction of eligible patients are actually […]
View Blog
Insights from the August 2024 Bridging the Gap Webinar In the evolving landscape of cell and gene therapy, the manufacturing process is a crucial factor in ensuring that innovative treatments, such as CAR T-cell therapies, reach patients effectively. Autologous cell therapies, which involve modifying a patient’s own cells, present unique challenges that require precise coordination […]
View Blog
Highlights from our July 2024 Bridging the Gap webinar Imagine harnessing your body’s own immune cells to fight and destroy cancer—a reality that Tumor-Infiltrating Lymphocytes (TIL) therapy is making possible. TIL therapy was the key topic of our July “Bridging the Gap” webinar with guest speaker Raj Puri, M.D., Ph.D. Dr. Puri, an Executive Vice […]
View Blog
Summary from Bridging the Gap Webinar Series May 2024 Welcome to another installment of the Bridging the Gap webinar series, your go-to place for the latest in cell and gene therapy. Presented by Azenta Life Sciences and the Emily Whitehead Foundation, this series is all about connecting the dots between groundbreaking science and real-world patient care. […]
View Blog
Highlights from the June 2024 Bridging the Gap Webinar What if you could transform the life of a child with leukemia by simply modifying their own cells? This is the promise of CAR T-cell therapy, a groundbreaking treatment that has already revolutionized cancer care. Yet, as Siddhartha Mukherjee, M.D., Ph.D. passionately discussed in our latest Bridging […]
View Blog
Insights from the “Bridging the Gap” Webinar, April 2024 The April 5, 2024, the Bridging the Gap webinar brought together experts and patients in a dynamic discussion that highlighted the groundbreaking advancements and persistent challenges in the field of cell and gene therapy (CGT), particularly in cancer immunotherapy. Guest speakers Kristen Hege, MD, former SVP, […]
View Blog